Back
Vertex Pharmaceuticals Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
47
VRTX
Vertex Pharmaceuticals
Last Price:
$469.74
Seasonality Move:
3.1%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VRTX is experiencing buying pressure, which is a positive indicator for future bullish movement.
Vertex Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 469.9 | Sell |
| 20-day SMA: | 456.44 | Buy |
| 50-day SMA: | 449.12 | Buy |
| 200-day SMA: | 463.11 | Buy |
| 8-day EMA: | 389.33 | Buy |
| 20-day EMA: | 237.24 | Buy |
| 50-day EMA: | 115.1 | Buy |
| 200-day EMA: | 31.87 | Buy |
Vertex Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 128.3 | Buy |
| Relative Strength Index (14 RSI): | 57.54 | Buy |
| Chaikin Money Flow: | 411563 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (444.56 - 467.38) | Buy |
| Bollinger Bands (100): | (445.32 - 495.26) | Sell |
Vertex Pharmaceuticals Technical Analysis
| Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul | ||||||||||
| 02 | 03 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Vertex Pharmaceuticals Stock
Is Vertex Pharmaceuticals Stock a Buy?
-
Vertex Pharmaceuticals share price is 469.55 while VRTX 8-day simple moving average is 469.90, which is a Sell signal.
-
The stock price of VRTX is 469.55 while Vertex Pharmaceuticals 20-day SMA is 456.44, which makes it a Buy.
-
Vertex Pharmaceuticals 50-day simple moving average is 449.12 while VRTX share price is 469.55, making it a Buy technically.
-
VRTX stock price is 469.55 and Vertex Pharmaceuticals 200-day simple moving average is 463.11, creating a Buy signal.
VRTX Technical Analysis vs Fundamental Analysis
Sell
47
Vertex Pharmaceuticals (VRTX)
is a Sell
Is Vertex Pharmaceuticals a Buy or a Sell?
-
Vertex Pharmaceuticals stock is rated a SellThe current Vertex Pharmaceuticals [VRTX] share price is $469.55. The Score for VRTX is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
Vertex Pharmaceuticals Stock Info
Market Cap:
120.6B
Price in USD:
469.55
Share Volume:
785.5K
Vertex Pharmaceuticals 52-Week Range
52-Week High:
519.88
52-Week Low:
377.85
Sell
47
Vertex Pharmaceuticals (VRTX)
is a Sell
Vertex Pharmaceuticals Share Price Forecast
-
What is the Vertex Pharmaceuticals stock price today?The Vertex Pharmaceuticals stock price is 469.55 USD today.
-
Will VRTX stock go up or go down?Vertex Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Vertex Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Vertex Pharmaceuticals is overvalued.
Is Vertex Pharmaceuticals Stock a Buy?
-
Vertex Pharmaceuticals share price is 469.55 while VRTX 8-day exponential moving average is 389.33, which is a Buy signal.
-
The stock price of VRTX is 469.55 while Vertex Pharmaceuticals 20-day EMA is 237.24, which makes it a Buy.
-
Vertex Pharmaceuticals 50-day exponential moving average is 115.10 while VRTX share price is 469.55, making it a Buy technically.
-
VRTX stock price is 469.55 and Vertex Pharmaceuticals 200-day simple moving average is 31.87, creating a Buy signal.
Fundamental Analysis of Vertex Pharmaceuticals
Is Vertex Pharmaceuticals a good investment?
-
Analysts estimate an earnings increase this quarter of $0.47 per share, an increase next quarter of $0.39 per share, an increase this year of $17.44 per share, and an increase next year of $2.60 per share.
Technical Analysis of Vertex Pharmaceuticals
Should I short Vertex Pharmaceuticals stock?
-
VRTX Moving Average Covergence Divergence (MACD) indicator is 128.3, suggesting Vertex Pharmaceuticals is a Buy
-
Vertex Pharmaceuticals Relative Strength Index (RSI) is 57.54, which suggest Vertex Pharmaceuticals is overbought
-
The Bollinger Bands (25) for Vertex Pharmaceuticals is (444.56 - 467.38), which suggest Vertex Pharmaceuticals is a Sell
-
The Bollinger Bands (100) for Vertex Pharmaceuticals is (445.32 - 495.26), which suggest Vertex Pharmaceuticals is a Sell
* Vertex Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.